CAS: 1239908-20-3 - Ixazomib citrate

Fórmula: C₂₀H₂₃BCl₂N₂O₉

InChI: InChI=1S/C20H23BCl2N2O9/c1-10(2)5-14(21-33-19(32)20(34-21,7-16(27)28)8-17(29)30)25-15(26)9-24-18(31)12-6-11(22)3-4-13(12)23/h3-4,6,10,14H,5,7-9H2,1-2H3,(H,24,31)(H,25,26)(H,27,28)(H,29,30)/t14-/m0/s1

Chave InChI: InChIKey=MBOMYENWWXQSNW-AWEZNQCLSA-N

SMILES: O=C(O)CC1(OB(OC1=O)C(NC(=O)CNC(=O)C2=CC(Cl)=CC=C2Cl)CC(C)C)CC(=O)O

1,3,2-Dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-

CAS: 1239908-20-3

• Fórmula: C₂₀H₂₃BCl₂N₂O₉
• Pureza: 97%
• Cor e Forma: Solid
• Peso molecular: 517.1216

Ixazomib citrate

CAS: 1239908-20-3

• Pureza: 98%
• Peso molecular: 517.1199951171875

Ixazomib Impurity 23 (Ixazomib Citrate)

CAS: 1239908-20-3

• Fórmula: C₂₀H₂₃BCl₂N₂O₉
• Peso molecular: 517.12

Ixazomib citrate [MLN9708]

CAS: 1239908-20-3

Ixazomib citrate

CAS: 1239908-20-3

Ixazomib citrate (MLN9708) is a prodrug of Ixazomib (MMLN-2238). MLN9708 is an orally bioavailable second …

• Fórmula: C₂₀H₂₃BCl₂N₂O₉
• Pureza: 100%
• Cor e Forma: Solid
• Peso molecular: 517.12

Ixazomibe citrate

CAS: 1239908-20-3

Proteosome inhibitor; antineoplastic

• Fórmula: C₁₄H₁₉BCl₂N₂O₄
• Pureza: Min. 95%
• Peso molecular: 361.03 g/mol